Arkolith/Insider Trading/RSLS/Form 4

Stankovich Thomas

Chief Financial OfficerReShape Lifesciences Inc. (RSLS) · full profile →Form 4 · filed Nov 8, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$386
Net Open-Market Flow
-$386
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 25, 2023Sell(S)131$0.27$3523K
Oct 11, 2023Sell(S)39$0.93$3623K
Sep 1, 2023Sell(S)118$0.89$10523K
Aug 24, 2023Sell(S)39$1.42$5523K
Aug 4, 2023Sell(S)108$1.43$15423K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001235802-23-000110) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML